Notable Upgrades: Synaptics (SYNA), eBay Inc. (EBAY), Tesla (TSLA), Pozen Inc. (POZN), OvaScience, Inc. (OVAS)

Analysts at Oppenheimer are out with a report this morning upgrading shares of Synaptics Inc. (SYNA) with an ‘Outperform‘ from ‘Perform‘ rating. The firm set its price target for the company at $105.

Synaptics Inc. shares are currently priced at 30.14x this year’s forecasted earnings, which makes them expensive compared to the industry’s 14.37x earnings multiple. Ticker has a forward P/E of 12.56 and t-12 price-to-sales ratio of 2.07. EPS for the same period is $2.93.

In the past 52 weeks, shares of San Jose, California-based company have traded between a low of $58.22 and a high of $102.50 and are now at $88.44. Shares are down 2.71% year-over-year ; up 25.39% year-to-date.

eBay Inc. (EBAY) was reiterated a ‘Neutral’ by JP Morgan (JPM) analysts on Monday. The broker also raised its price target on the stock to $64 from $60.

EBAY shares recently lost $0.60 to $60.44. JPM’s target price suggests a potential upside of about 7% from the company’s current stock price.

In the past 52 weeks, shares of San Jose, Calif.-based company have traded between a low of $46.34 and a high of $63.30. Shares are up 23.39% year-over-year and 8.77% year-to-date.

Analysts at Credit Suisse (CS) are out with a report this morning reiterating shares of Tesla Motors (TSLA) as ‘Outperform’ with a $325 from $290 price target.

Tesla Motors Inc. shares have a forward P/E of 77.21 and t-12 price-to-sales ratio of 9.60. EPS for the same period is ($3.18).  Over the past year, shares of the electric car maker have traded between a low of $181.40 and a high of $291.42 and are now at $263.90. Shares are up 13.37% year-over-year and 20.09% year-to-date.

Pozen Inc. (POZN) rating of ‘Buy’ was reiterated today at Chardan Capital Markets with a price target increase of $15.50 from $10 (versus a $11.01 previous close).

POZN began trading this morning at $10.96 to currently trade 1.00% lower from the prior days close of $11.01. On an intraday basis it has gotten as low as $10.73 and as high as $11.06.

Pozen Inc. shares are priced at 21.33x this year’s forecasted earnings, compared to the industry’s 1.45x earnings multiple. The company’s current year and next year EPS growth estimates stand at 11.70% and 9.00% compared to the industry growth rates of 48.60% and 90.40%, respectively. POZN has a t-12 price-to-sales ratio of 12.19. EPS for the same period registers at $0.51.

Pozen shares have advanced 68.09% in the last 4 weeks and 43.36% in the past three months. Over the past 5 trading sessions the stock has lost 4.84%.

The Chapel Hill, North Carolina-based company, which is currently valued at $353.40 million, has a median Wall Street price target of $10.00 with a high target of $10.00. Pozen Inc. is up 33.94% year-over-year, compared with a 7.17% gain in the S&P 500.

In a report published Monday, JP Morgan (JPM) analysts initiated coverage on OvaScience, Inc. (OVAS) with a ‘Neutral‘ rating and $40 price target.

Currently there are 6 analysts that rate OVAS versus no analysts rating it a ‘Sell’. The stock has a median Wall Street price target of $52.50 with a high target of $100.00.

In the past 52 weeks, shares of Cambridge, Massachusetts-based company have traded between a low of $8.73 and a high of $55.69 and are now at $29.49. Shares are up 227.77% year-over-year ; down 32.47% year-to-date.

Be the first to comment

Leave a Reply

Your email address will not be published.


*